Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis
Colm Elliott(NeuroRx Research (Canada)), Douglas L. Arnold(McGill University), Julian Fecker(Roche (Switzerland)), Fabian Model(University Hospital of Basel), Ludwig Kappos(University Hospital of Basel), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Jerry S. Wolinsky(The University of Texas Health Science Center at Houston), Wei Wei(Roche (Switzerland)), Corrado Bernasconi(Roche (Switzerland)), Stephen L. Hauser(University of California, San Francisco), Shibeshih Belachew(Roche (Switzerland))
Cited by 217
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k